Faceptor
NNG17.1
Phase 3 small_molecule completed
Quick answer
Faceptor for Breast Cancer Metastatic is a Phase 3 program (small_molecule) at Biotech Pharmaceutical Co., with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Breast Cancer Metastatic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed